Cargando…

Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension

Ocular hypertension (OHT) caused by inflammation or corticosteroid treatment is a common complication of uveitis. Ripasudil hydrochloride hydrate (K-115) is reportedly efficacious for lowering intraocular pressure (IOP). We retrospectively compared the IOP-lowering effect of K-115 for inflammatory a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasuda, Mami, Takayama, Kei, Kanda, Takayuki, Taguchi, Manzo, Someya, Hideaki, Takeuchi, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624590/ https://www.ncbi.nlm.nih.gov/pubmed/28968412 http://dx.doi.org/10.1371/journal.pone.0185305

Ejemplares similares

Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection
por: Kusuhara, Sentaro, et al.
Publicado: (2020)

Topical Corticosteroid-Resolved Rubeosis Iridis with Neovascular Glaucoma Caused by Noninfectious Granulomatous Uveitis
por: Sora, Daisuke, et al.
Publicado: (2018)

Age-related differences in the clinical features of ocular sarcoidosis
por: Takayama, Kei, et al.
Publicado: (2018)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
por: Sato, Tomohito, et al.
Publicado: (2021)

Intraocular pressure-lowering effects of Ripasudil: a potential outcome marker for Trabeculotomy
por: Goda, Erina, et al.
Publicado: (2019)

Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months
por: Tanihara, Hidenobu, et al.
Publicado: (2022)

Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys
por: Kaneko, Yoshio, et al.
Publicado: (2017)

Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report
por: Taguchi, Manzo, et al.
Publicado: (2017)

Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
por: Tanihara, Hidenobu, et al.
Publicado: (2023)

Effect of ripasudil on diabetic macular edema
por: Minami, Yoshiro, et al.
Publicado: (2019)

Ripasudil in a Model of Pigmentary Glaucoma
por: Wang, Chao, et al.
Publicado: (2020)

Circadian Fluctuation Changes in Intraocular Pressure Measured Using a Contact Lens Sensor in Patients with Glaucoma after the Adjunctive Administration of Ripasudil: A Prospective Study
por: Huang, Shih-Kung, et al.
Publicado: (2023)

Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report
por: Sakurai, Yutaka, et al.
Publicado: (2020)

Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
por: Futakuchi, Akiko, et al.
Publicado: (2020)

Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma
por: Mohapatra, Sumita, et al.
Publicado: (2023)

Chronic postcataract endophthalmitis caused by Penicillium species in an immunocompetent patient
por: Kanda, Koji, et al.
Publicado: (2018)

Topical Ripasudil for the Treatment of Primary Corneal Endothelial Degeneration in Dogs
por: Michalak, Sarah R., et al.
Publicado: (2022)

Influence of Ocular Surface Hydration on Intra-Operative Aberrometry Measurement and Toric Intraocular Lens Recommendation
por: He, George, et al.
Publicado: (2022)

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
por: Araie, Makoto, et al.
Publicado: (2023)

Thermoresponsive sol-gel improves ocular bioavailability of Dipivefrin hydrochloride and potentially reduces the elevated intraocular pressure in vivo
por: Alkholief, Musaed, et al.
Publicado: (2020)

Topical ripasudil stimulates neuroprotection and axon regeneration in adult mice following optic nerve injury
por: Nishijima, Euido, et al.
Publicado: (2020)

Intraocular pressure: Focus on corticosteroids
por: Shukla, Dhananjay
Publicado: (2021)

Evaluation of Microincision Vitrectomy Surgery Using Wide-Viewing System for Complications With Ocular Sarcoidosis
por: Takayama, Kei, et al.
Publicado: (2015)

A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
por: Mizuno, Yu, et al.
Publicado: (2023)

Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment
por: Wang, Xuemei, et al.
Publicado: (2022)

Favorable effect of ripasudil use on surgical outcomes of microhook ab interno trabeculotomy
por: Okuda, Mina, et al.
Publicado: (2023)

Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
por: Tanihara, Hidenobu, et al.
Publicado: (2020)

Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
por: Tanihara, Hidenobu, et al.
Publicado: (2019)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Bilateral idiopathic retinal vasculitis following coxsackievirus A4 infection: a case report
por: Mine, Izumi, et al.
Publicado: (2017)

Better Visual Outcome by Intraocular Lens Ejection in Geriatric Patients with Ruptured Ocular Injuries
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
por: Tanihara, Hidenobu, et al.
Publicado: (2020)

Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival
por: Inomata, Takenori, et al.
Publicado: (2020)

Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
por: Sato, Tomoki, et al.
Publicado: (2021)

A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity
por: Sugimoto, Koichi, et al.
Publicado: (2015)

Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study
por: Mizuno, Yu, et al.
Publicado: (2022)

Aqueous column changes in the episcleral veins after the instillation of ripasudil versus latanoprost: a randomized, double-blind, crossover clinical trial
por: Suzuki, Marie, et al.
Publicado: (2022)

Ocular Microbiota and Intraocular Inflammation
por: Li, Jing Jing, et al.
Publicado: (2020)

Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
por: Sakamoto, Emi, et al.
Publicado: (2019)

Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapy
por: Jethva, Jignesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gm6mtg2patcgjlfot3v85a11j2